Search the web
Welcome, Guest
[Sign Out, My Account]

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
GNMX > SEC Filings for GNMX > Form 8-K on 20-Mar-2017All Recent SEC Filings

Show all filings for AEVI GENOMIC MEDICINE, INC.



Regulation FD Disclosure, Financial Statements and Exhibits

Item 7.01. Regulation FD Disclosure.

On March 20, 2017, Aevi Genomic Medicine, Inc. (the "Company") issued a press release announcing topline results from the SAGA trial of AEVI001 (oral nonstimulant) in adolescents with mGluR mutation positive (mGluR+) ADHD. The press release is attached as Exhibit 99.1 hereto and is incorporated herein by reference.

The Company hosted a conference call and live audio webcast on Monday, March 20, 2017 to discuss the results from the SAGA trial of AEVI001. The Company referred to the slide presentation, attached as Exhibit 99.2 and incorporated by reference herein, on the conference call. The slide presentation, together with an archive of the webcast, will also be available for 30 days after the date of the conference call in the Investor section of the Company's website at

The information in this Item 7.01 disclosure, including Exhibit 99.1 and Exhibit 99.2, is being furnished and shall not be deemed "filed" for purposes of
Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities under that Section. In addition, the information in this Item 7.01 disclosure, including Exhibit 99.1 and Exhibit 99.2, shall not be incorporated by reference into the filings of the Company under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits. The following exhibits are furnished herewith:

Exhibit No. Description

99.1        Aevi Genomic Medicine, Inc. Press Release dated March 20, 2017
            (furnished pursuant to Item 7.01).

99.2        Slide Presentation dated March 20, 2017 (furnished pursuant to Item

  Add GNMX to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for GNMX - All Recent SEC Filings
Copyright © 2017 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.